FSD1L anticorps
-
- Antigène Voir toutes FSD1L Anticorps
- FSD1L (Fibronectin Type III and SPRY Domain Containing 1-Like (FSD1L))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp FSD1L est non-conjugé
-
Application
- Western Blotting (WB)
- Fonction
- Mouse polyclonal antibody raised against a full-length human FSD1NL protein.
- Séquence
- MDSQKEALQR IISTLANKND EIQNFIDTLH HTLKGVQENS SNILSELDEE FDSLYSILDE VKESMINCIK QEQARKSQEL QSQISQCNNA LENSEELLEF ATRSLDIKEP EEFSKVHKNC INTLNKGSCI FKKAFLFFFS FGFLY
- Réactivité croisée
- Humain
- Attributs du produit
- Antibody reactive against mammalian transfected lysate.
- Immunogène
- FSD1NL (NP_114125.1, 1 a.a. ~ 145 a.a) full-length human protein.
- Top Product
- Discover our top product FSD1L Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Antibody generated from annotated, sequenced verified full-length protein. Checked against mammalian transfected lysate for demonstration of high antibody reactivity, sensitivity, and specificity. This antibody has the ability to recognize multiple protein epitopes, thus maximizing antibody performance and their applications.
- Restrictions
- For Research Use only
-
- Buffer
- In 1x PBS, pH 7.4
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Antigène
- FSD1L (Fibronectin Type III and SPRY Domain Containing 1-Like (FSD1L))
- Autre désignation
- FSD1L (FSD1L Produits)
- Synonymes
- anticorps CCDC10, anticorps CSDUFD1, anticorps FSD1CL, anticorps FSD1NL, anticorps MIR1, anticorps A230072O16Rik, anticorps Ccdc10, anticorps Csdufd1, anticorps Fsd1nl, anticorps OTTMUSG00000007002, anticorps RGD1564809, anticorps fibronectin type III and SPRY domain containing 1 like, anticorps fibronectin type III and SPRY domain containing 1-like, anticorps FSD1L, anticorps Fsd1l
- Sujet
- Fibronectin type III and SPRY domain containing 1-like
- ID gène
- 83856
- NCBI Accession
- NM_031919
-